NRSF Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NRSF monoclonal antibodies for investigating the neuron-restrictive silencer factor (NRSF) in various biological processes. NRSF monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NRSF functions as a transcriptional repressor that regulates the expression of neuronal genes in non-neuronal tissues, playing a vital role in maintaining neuronal identity and function. Research has shown that NRSF dysregulation can contribute to various neurological conditions, including neurodegeneration and cancer. Understanding NRSF mechanisms and pathways can reveal potential therapeutic targets for treating these diseases. Researchers worldwide utilize NRSF monoclonal antibodies to explore cellular signaling pathways and gene regulation. Advanced research techniques incorporating NRSF monoclonal antibodies enable detailed analysis of protein expression and localization. Ongoing studies with NRSF monoclonal antibodies continue to expand scientific knowledge of neurological development and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing neuroscience and contributing to breakthrough discoveries in neurological research.